Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Biomarkers of immunosuppressant organ toxicity after transplantation: status, concepts and misconceptions.

Expert opinion on drug metabolism & toxicology - 1 Feb 2011

Christians Uwe, Klawitter Jost, Klawitter Jelena, Brunner Nina, Schmitz Volker

Abstract excerpt

INTRODUCTION: A major challenge in transplantation is improving long-term organ transplant and patient survival. Immunosuppressants protect the transplant organ from alloimmune reactions, but sometimes also exhibit limiting side effects. The key to improving long-term outcome following transplantation is the selection of the correct immunosuppressive regimen for an individual patient for minimizing toxicity while...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers
Share to Genotype

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Immunosuppressive Agents

Share to Kidney Transplantation

Share to Metabolome

Share to Phenotype

Share to Proteomics

Share to Signal Transduction

Source

Open in PubMed Open full text

Identifiers

PMID: 21241200
DOI: 10.1517/17425255.2011.544249
PMCID: PMC3079351

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Biomarkers of immunosuppressant organ toxicity after transplantation: status, concepts and misconceptions.PMID 21241200Read ↗

Non-invasive biomarkers to guide management following renal transplantation: the need for a multiplatform approach.Semantic proximity Read ↗

Biomarkers in solid organ transplantation: establishing personalized transplantation medicineSemantic proximity Read ↗

Understanding and Preventing Adverse Effects of Tacrolimus Metabolization in Transplant Patients.Semantic proximity Read ↗

Trends in Precision Medicine and Pharmacogenetics as an Adjuvant in Establishing a Correct Immunosuppressive Therapy for Kidney Transplant: An Up-to-Date Historical OverviewSemantic proximity Read ↗

Analytical and Omics-Based Advances in the Study of Drug-Induced Liver InjurySemantic proximity Read ↗

Immunogenomics and proteomics in hematopoietic stem cell transplantation: predicting post-hematopoietic stem cell transplant complications.Semantic proximity Read ↗

Transplantomics and Biomarkers in Organ Transplantation: A Report From the First International ConferenceSemantic proximity Read ↗

Graft-versus-host disease biomarkers: omics and personalized medicine.Semantic proximity Read ↗

Systems Biology in Kidney Transplantation: The Application of Multi-Omics to a Complex ModelSemantic proximity Read ↗

Systematic Review: Clinical Metabolomics to Forecast Outcomes in Liver Transplantation Surgery.Semantic proximity Read ↗

Evolving Biomarkers in Kidney TransplantationSemantic proximity Read ↗

Metabolomics approaches for discovering biomarkers of drug-induced hepatotoxicity and nephrotoxicity.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.